Droopy eyelid after Botox: why, how long and what to do
An eyelid that droops a few days after an injection is a known adverse effect of botulinum toxin. It is temporary: it goes away when the effect of the toxin wears off. Here is why it happens, how long it lasts, what can help in the meantime and when to see a doctor without delay.
A drooping eyelid, which doctors call eyelid ptosis, is one of the best-known eyelid problems after a botulinum toxin injection. It affects only a small proportion of injections and does not put the eye at risk, but it is bothersome, visible and sometimes worrying. A review of the literature stresses that it remains rare, and more frequent when the practitioner has little experience1. This page answers the seven questions people ask most often. If your eyelid has just started to droop, remember this first: the effect is known, it is temporary, and your doctor can help you while you wait for it to go away.
Why does the eyelid droop after an injection?
The upper eyelid is held open by a muscle called the levator of the upper eyelid, located inside the eye socket. When botulinum toxin injected into a nearby area, most often between the eyebrows, spreads to this muscle, it weakens it too: the eyelid drops1. An anatomical study by the authors of the same review showed that a small opening in the bone, present above the eye in some people, can act as a direct passage from the eyebrow area to the roof of the eye socket1.
This is why the labels ask practitioners to avoid injecting near the levator muscle of the eyelid, and specify how high above the rim of the eye socket the injection points should be2,3,6. A review also recommends staying 1.5 cm above the eyebrow, in line with the pupil, when treating the forehead7.
Ptosis is described in the labels of type A toxins as well as in that of the short-acting toxin. For one type A toxin, it is common after treatment of frown lines2; for another, it is uncommon6. With the short-acting botulinum toxin (serotype E), it was reported in 0.17% of patients3. These frequencies come from different trials: they cannot be used to compare the products.
How soon after the injection does it appear?
It usually appears 3 to 14 days after the injection1. In trials of a type A toxin covering treatment of the forehead and frown lines, the median time to onset was 9 days after treatment2. For the short-acting toxin, whose first effects appear from 8 hours3, this time has not been published.
How long does it last?
Most often a few weeks: the eyelid lifts again as the effect of the toxin wears off1. In one case series, however, troublesome ptosis persisted from 6 weeks to 13 months4. The authors suggest a benchmark: in patients whose eyelid lifts with apraclonidine eye drops after a one-week trial, the ptosis probably resolves within 4 to 6 weeks; in those who do not respond, it may last longer4.
Duration also depends on the toxin injected: about 2–3 weeks of effect for the short-acting toxin3, several months for a type A toxin2. The short-acting toxin is approved for frown lines in the European Union since 15 July 2026 and in Canada since 22 June 20268,9. These durations are explained on the page about how long botulinum toxin lasts, and the comparison of the two families of toxins summarises their profiles.
Is there a treatment?
Eye drops prescribed by a doctor, containing apraclonidine or oxymetazoline in particular, can partly lift the eyelid while you wait for recovery1,4. Oxymetazoline eye drops were evaluated in two phase 3 trials in adults with acquired ptosis: they lifted the eyelid within minutes of being applied, and this effect was maintained at day 425. These trials did not specifically involve ptosis caused by botulinum toxin.
These eye drops act on a small accessory muscle of the eyelid; they do not make the toxin wear off any faster. The review also mentions other options, to be discussed with a specialist1. No massage, cream or exercise has shown any effect in the sources we consulted. The eye drops are used only on prescription, after an examination: the doctor first checks that they are suitable for you.
What should you avoid?
Do not use eye drops without medical advice. Do not change a current treatment on your own. Avoid massaging the area or manipulating the eyelid. Do not try to "correct" the problem with an early new injection: after a short-acting toxin, a type A toxin injected less than 30 days later has not been evaluated3. Avoid driving if the eyelid gets in the way of your field of vision: the label of a botulinum toxin points out this risk3.
When should you see a doctor?
Talk to your doctor as soon as the eyelid droops, to confirm that this is what is happening, and not an eyebrow that is dropping, and to discuss eye drops. See a doctor without delay if the eye becomes painful or very dry, if the eyelid covers the pupil, or if the problem is not improving. For this appointment, write down the date of the injection, the area treated and the day the eyelid started to droop: these details help confirm the link with the injection.
When to seek medical advice quickly
- Blurred or double vision
- Difficulty swallowing, speaking or breathing
Breathing, swallowing or vision problems: call the emergency services (15 or 112 in France).
Other problems can affect the same area, such as puffy eyelids after an injection, or an eyebrow that droops, which is often confused with a drooping eyelid.
Key points
- The eyelid droops when the toxin spreads to the levator muscle of the upper eyelid1.
- It usually appears 3 to 14 days after the injection, with a median of 9 days in trials of a type A toxin1,2.
- It is reversible and goes away when the effect of the toxin wears off, most often within a few weeks1.
- Prescription eye drops can partly lift the eyelid in the meantime1,4.
Frequently asked questions
Can a drooping eyelid after an injection last several months?
It is rare. In most cases, the eyelid lifts again when the effect of the toxin wears off1. A series of seven patients referred to a specialist service, however, describes troublesome ptosis that lasted from 6 weeks to 13 months4. If the problem persists, talk to your doctor: they can suggest prescription eye drops and, depending on how you respond to them, estimate the recovery time4.
Can I drive with a drooping eyelid?
Be careful. The label of a botulinum toxin points out that a drooping eyelid and visual disturbances could affect the ability to drive and use machines3. If your eyelid covers part of your field of vision, or if your vision is blurred or double, do not drive and seek medical advice. An eyelid that is barely lowered, with no effect on your vision, can be discussed with your doctor.
Sources
- 1.Nestor M.S. et al., eyelid ptosis after botulinum toxin: a review, Journal of Cosmetic Dermatology, 2021 (opens in a new tab) — Journal of Cosmetic Dermatology
- 2.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
- 3.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
- 4.Steinsapir K.D. et al., case series of ptosis after botulinum toxin, Dermatologic Surgery, 2015 (opens in a new tab) — Dermatologic Surgery
- 5.Bacharach J. et al., oxymetazoline eye drops for acquired ptosis: phase 3 trial, Clinical Ophthalmology, 2021 (opens in a new tab) — Clinical Ophthalmology
- 6.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 61592762) (opens in a new tab) — French public medicines database (BDPM)
- 7.Borba A. et al., avoiding complications of upper face treatment with botulinum toxin: a practical guide, Aesthetic Plastic Surgery, 2022 (opens in a new tab) — Aesthetic Plastic Surgery
- 8.European public assessment report (EPAR) of the serotype E botulinum toxin (opens in a new tab) — European Commission (Union Register of medicinal products)
- 9.Canadian product monograph of the serotype E botulinum toxin (authorization date: 2026-06-22) (opens in a new tab) — Health Canada